Common Pediatric Diseases and Disorders
Allergic diseases are hypersensitivity reactions where the immune system overreacts to harmless environmental substances (allergens). From hay fever to life-threatening anaphylaxis, these conditions significantly impact children's quality of life and require comprehensive management strategies. Understanding the "atopic march" - the natural progression from eczema to allergic rhinitis to asthma - is key to holistic management.
🎯 Understanding Childhood Allergies
Allergic conditions represent immune system dysregulation with varying clinical presentations and management approaches:
🔥 Allergic Rhinitis (Hay Fever)
- Prevalence: 10-30% of children worldwide
- Pathophysiology: Type I hypersensitivity (IgE-mediated) reaction
- Triggers: Pollen (seasonal), dust mites, pets, mold (perennial)
- Presentation: Nasal congestion, rhinorrhea, sneezing, itching (nose/eyes/palate)
- Physical signs: Allergic shiners, nasal crease, pale boggy mucosa
- Key Point: Often coexists with asthma (united airway disease)
📈 Food Allergies
- Prevalence: 6-8% of young children; rising globally
- Common allergens: Milk, egg, peanut, tree nuts, soy, wheat, fish, shellfish, sesame
- Presentation: Immediate (IgE) vs delayed (non-IgE) reactions
- Natural history: Most outgrow milk/egg by school age; peanut/tree nut/seafood often lifelong
- Prevention: Early introduction (4-6 months) reduces risk
- Key Point: Anaphylaxis risk requires epinephrine auto-injector availability
📉 Atopic Dermatitis (Eczema)
- Prevalence: 10-20% of children, usually starts in infancy
- Pathophysiology: Barrier dysfunction (filaggrin mutations), immune dysregulation
- Distribution: Infants: cheeks/extensors; Children: flexural areas
- Triggers: Irritants, allergens, infections, stress, temperature changes
- Complications: Skin infections (Staph aureus, HSV), sleep disturbance
- Key Point: Foundation = moisturization; steroids for inflammation
🎯 Clinical Memory Aid: The "Atopic March" Progression
- Infancy (3-6 months): Atopic dermatitis (eczema)
- Toddler (1-3 years): Food allergies
- Preschool (3-5 years): Allergic rhinitis
- School age (5+ years): Asthma
- Key Principle: Early intervention at each stage may modify progression
💊 Pharmacologic Management of Allergic Conditions
Stepwise approach to allergic disease management with emphasis on appropriate medication selection:
👃 Allergic Rhinitis Treatment
- First-line: Intranasal corticosteroids (fluticasone, mometasone, budesonide) Onset: 1-2 days; full effect: 1-2 weeks
- Second-line: Oral antihistamines (cetirizine, loratadine, fexofenadine) Second-generation preferred (less sedation, longer duration)
- Add-on: Leukotriene receptor antagonists (montelukast) Especially if coexistent asthma
- Rescue: Intranasal antihistamines (azelastine) Fast onset (15-30 min) but shorter duration
- Key Point: Start intranasal steroids BEFORE pollen season for seasonal allergies
🍤 Food Allergy Management
- Emergency treatment: Epinephrine IM (0.01 mg/kg, max 0.3-0.5 mg) FIRST-LINE for anaphylaxis; NEVER delayed for antihistamines
- Adjuvant: H1-antihistamines (diphenhydramine, cetirizine) For mild cutaneous symptoms ONLY; not for respiratory/cardiovascular symptoms
- Prevention: Oral immunotherapy (OIT) for select patients Gradual desensitization under specialist supervision
- Key Point: Always prescribe TWO epinephrine auto-injectors (second for biphasic reaction)
🔬 Atopic Dermatitis Therapy
- Foundation: Moisturizers (ointment > cream > lotion) Apply immediately after bathing (within 3 minutes)
- Anti-inflammatory: Topical corticosteroids (potency based on location/severity) Face/flexures: low potency (hydrocortisone); Body: medium/high
- Steroid-sparing: Topical calcineurin inhibitors (tacrolimus, pimecrolimus) For face/neck, steroid-resistant areas; avoid in children <2 years
- Severe cases: Systemic therapy (cyclosporine, methotrexate, dupilumab) Specialist management only
🌀 Urticaria/Angioedema Approach
- First-line: Second-generation H1-antihistamines (cetirizine, loratadine) Daily use for chronic urticaria; can increase to 4x standard dose
- Add-on: H2-antihistamines (famotidine, ranitidine) Especially if gastrointestinal symptoms prominent
- Refractory: Omalizumab (anti-IgE) for chronic spontaneous urticaria Highly effective (70-80% response) but expensive
- Key Point: Short-course oral steroids ONLY for severe acute exacerbations
⚠️ CRITICAL WARNING: ANAPHYLAXIS MANAGEMENT PRIORITIES
- 1. EPINEPHRINE FIRST: IM in outer thigh (NOT subcutaneous, NOT IV push in non-hospital setting)
- 2. CALL FOR HELP: 911/ambulance immediately (even if symptoms improve)
- 3. POSITIONING: Lay flat, elevate legs (NOT sitting up - can cause "empty ventricle syndrome")
- 4. REPEAT EPINEPHRINE: Every 5-15 minutes if no improvement (up to 3 doses typically)
- 5. TRANSPORT: To ER for 4-6 hour observation (20% have biphasic reaction)
- ANTIHISTAMINES ARE ADJUNCTS ONLY: Never delay epinephrine for antihistamines
🏠 Environmental Control Strategies
Comprehensive allergen avoidance remains cornerstone of allergic disease management:
| Allergen | Evidence-Based Control Strategies | Effectiveness | Practical Tips |
|---|---|---|---|
| Dust Mites | • Allergen-proof mattress/pillow covers • Wash bedding weekly in hot water (>54°C/130°F) • Maintain humidity <50% • Remove carpets, stuffed toys |
High with comprehensive approach | Freeze stuffed toys overnight monthly; vacuum with HEPA filter |
| Pet Allergens | • Remove pet from home (most effective) • Keep pet out of bedroom • HEPA air filters • Weekly pet bathing |
High if pet removed; Moderate if kept | Cat allergens airborne for months after removal; dog allergens settle faster |
| Pollen | • Close windows during high pollen seasons • AC with HEPA filters • Shower/wash hair after outdoor exposure • Wear sunglasses outdoors |
Moderate to High | Check local pollen counts; highest in early morning and windy days |
| Mold | • Fix water leaks promptly • Dehumidifier (keep <50%) • Bathroom ventilation • Remove visible mold with bleach solution |
High with source elimination | Outdoor molds peak in fall; indoor molds year-round in damp areas |
| Tobacco Smoke | • Absolute prohibition indoors and in cars • No smoking near child • Encourage smoking cessation |
Critical for asthma/allergy control | Thirdhand smoke (residue on surfaces) also harmful; wash exposed items |
🩺 PRACTICAL ALLERGEN AVOIDANCE MNEMONIC: "CLEAN"
- Control humidity (<50%)
- Limit fabrics (carpets, curtains, upholstered furniture)
- Eliminate pets from bedrooms
- Air filtration (HEPA filters)
- No smoking (absolute prohibition)
🏃 Special Considerations: EIB & Adolescent Asthma
Exercise-induced bronchoconstriction (EIB) and adolescent asthma present unique management challenges:
⚡ Exercise-Induced Bronchoconstriction (EIB)
- Prevalence: 40-90% of asthmatics, 10% of general population
- Pathophysiology: Airway cooling/drying → mast cell degranulation → bronchoconstriction
- Clinical features: Symptoms peak 5-10 minutes post-exercise, resolve in 30-60 minutes
- Diagnosis: Clinical history ± exercise challenge test
- Prevention: SABA 15-30 minutes pre-exercise; leukotriene modifiers for frequent need
- Key Point: EIB should NOT limit sports participation with proper management
💀 Adolescent Asthma Challenges
- Highest mortality period: Poor adherence, risk-taking behavior, denial
- Adherence barriers: Embarrassment, forgetfulness, perceived invincibility
- Risk factors: Smoking/vaping, substance use, mental health issues
- Management strategies:
- Involve adolescent in decision-making
- Simplify regimens (once-daily dosing)
- Address mental health
- Gradual transition to adult care - Key Point: Adolescents need developmentally appropriate education and empowerment
📊 EIB Management Algorithm
- Step 1: 15-minute warm-up before intense exercise Induces "refractory period" (1-3 hours of reduced bronchoconstriction)
- Step 2: SABA (albuterol) 15-30 minutes pre-exercise Provides 2-3 hours of protection; use spacer if MDI
- Step 3: Daily controller if SABA needed >2x/week for EIB ICS preferred; leukotriene modifier alternative
- Step 4: Face mask/scarf in cold/dry conditions Warms/humidifies inspired air; reduces EIB severity
- Step 5: Consider alternative if refractory: mast cell stabilizer (cromolyn) pre-exercise Less effective than SABA but no systemic effects
🚨 ADOLESCENT ASTHMA RED FLAGS:
- Frequent ED visits/hospitalizations (indicates poor control)
- No regular controller use despite persistent symptoms
- Smoking/vaping (directly worsens asthma)
- Depression/anxiety symptoms (affects adherence)
- Missing school frequently due to asthma
- ACTION: Intensive re-education, mental health referral, closer follow-up
📝 Asthma Action Plans: Essential Tool
Written asthma action plans (AAPs) empower patients/families and improve outcomes. Every child with asthma should have a personalized, written plan:
| Zone | Clinical Status | Symptoms/PEF | Actions |
|---|---|---|---|
| GREEN (Doing Well) |
Well-controlled asthma | • No daytime symptoms • No night waking • Normal activity • PEF >80% personal best |
• Continue daily controller medication • SABA before exercise if needed • Routine follow-up |
| YELLOW (Caution) |
Asthma worsening | • Cough, wheeze, chest tightness • Waking at night • Activity limited • PEF 50-80% personal best |
• SABA every 4 hours as needed • Continue controller • Consider short course oral steroids • Call doctor within 24-48 hours |
| RED (Medical Alert) |
Severe exacerbation | • Severe distress • Trouble speaking in full sentences • Lips/fingernails blue/gray • PEF <50% personal best |
• SABA immediately (can repeat every 20 min x3) • Oral steroids if not improving • CALL 911/GO TO ER NOW • Don't wait! |
🔥 HIGH-YIELD: AAP Essential Components
- Personalized: Child's name, photo, personal best PEF
- Medication-specific: Names, doses, frequencies for each zone
- Clear instructions: When to increase/decrease medications
- Emergency plan: When/how to seek emergency care
- Contact information: Doctor, pharmacy, emergency contacts
- Updated regularly: At every asthma visit (at least annually)
- Proven benefit: Reduces ED visits by 40%, hospitalizations by 60%
💉 Immunotherapy & Emerging Therapies
Immunotherapy modifies the immune response to allergens; emerging biologics target specific inflammatory pathways:
💉 Allergen Immunotherapy (AIT)
- Mechanism: Gradual exposure induces immune tolerance (Treg cells, IgG4 blocking antibodies)
- Forms: Subcutaneous (SCIT) vs Sublingual (SLIT)
- Indications: Moderate-severe allergic rhinitis, venom allergy, select asthma cases
- Duration: 3-5 years typically; can provide lasting benefit after discontinuation
- Efficacy: 80-85% for rhinitis; reduces asthma symptoms/medication use
- Safety: Risk of systemic reactions (higher with SCIT); requires monitoring
🧬 Biologic Therapies
- Omalizumab (anti-IgE): For moderate-severe allergic asthma, chronic urticaria
- Mepolizumab/Reslizumab/Benralizumab (anti-IL-5): For severe eosinophilic asthma
- Dupilumab (anti-IL-4/13): For moderate-severe atopic dermatitis, asthma, rhinosinusitis with polyps
- Indications: Severe, uncontrolled disease despite optimal conventional therapy
- Administration: Subcutaneous injections every 2-8 weeks
- Cost: Very expensive; requires specialist prescription/prior authorization
🍤 Oral Immunotherapy (OIT) for Food Allergy
- Process: Gradual, controlled ingestion of allergen (starting with micrograms)
- Goal: Desensitization (increased reaction threshold) NOT cure
- Efficacy: 60-80% achieve desensitization; must continue daily maintenance dose
- Safety: Side effects common (oral itching, abdominal pain); risk of systemic reactions
- Available for: Peanut (FDA-approved); others (milk, egg, tree nuts) investigational/off-label
- Key Point: NOT for all patients; requires careful selection, dedicated allergy center
🔍 IMMUNOTHERAPY CONSIDERATIONS:
- Patient selection: Specific IgE to clinically relevant allergens; not for multiple unrelated allergies
- Contraindications: Unstable asthma, autoimmune diseases, malignancy, pregnancy (don't start)
- Commitment required: Weekly visits for 6-12 months (SCIT build-up phase), then monthly
- Adherence critical: Irregular dosing reduces efficacy, increases reaction risk
- Monitor for efficacy: Should see improvement within 6-12 months; reassess at 1-2 years
🎯 Prevention Strategies
Primary and secondary prevention can modify allergy development and progression:
🛡️ PRIMARY PREVENTION (Before Allergy Develops)
- Early allergen introduction: Peanut at 4-6 months in high-risk infants reduces peanut allergy by 80% Based on LEAP study; applies to egg as well
- Probiotics: May reduce eczema risk when taken during pregnancy/lactation Mixed evidence; Lactobacillus rhamnosus GG most studied
- Vitamin D: Adequate levels may reduce allergy risk (controversial) Maintain levels >30 ng/mL during pregnancy/early childhood
- Breastfeeding: Exclusive for 4-6 months may reduce eczema/wheeze No clear effect on food allergy prevention
- Avoid smoking: During pregnancy and around child reduces asthma risk
🛡️ SECONDARY PREVENTION (After Allergy Develops)
- Allergen avoidance: For confirmed allergens to prevent reactions
- Early aggressive eczema treatment: May reduce food allergy risk Intact skin barrier prevents allergen sensitization
- Asthma control: Prevents progression to fixed airway obstruction
- Immunotherapy: May prevent new sensitizations and asthma development in rhinitis
- Education: Early recognition/treatment of reactions prevents severe outcomes
🧠 Key Clinical Pearls
Essential considerations for managing childhood asthma and allergies:
🎯 MUST-KNOW PEARLS FOR PRACTICE
- "Early peanut introduction prevents peanut allergy." Introduce at 4-6 months in high-risk infants (eczema, egg allergy).
- "Epinephrine FIRST for anaphylaxis." Antihistamines are adjuncts only; never delay epinephrine.
- "Most wheezing preschoolers don't have asthma." Use Asthma Predictive Index to identify true asthma.
- "Exercise symptoms should never limit sports." With proper management, athletes with asthma can excel.
- "Adolescence = highest asthma mortality risk." Address adherence, risk-taking, mental health.
- "Every child needs a written asthma action plan." Reduces ED visits by 40%.
- "Moisturize, moisturize, moisturize for eczema." Foundation of treatment > steroids.
- "Biphasic anaphylaxis occurs in 20%." Observe 4-6 hours after epinephrine.
- "Allergic rhinitis treatment improves asthma control." United airway disease concept.
- "Environmental control works." Comprehensive approach reduces symptoms/medication needs.
⚠️ COMMON PITFALLS TO AVOID:
- Delaying epinephrine in anaphylaxis: Minutes matter; don't wait for "severe" symptoms
- Over-relying on antihistamines: They don't treat respiratory/cardiovascular symptoms
- Under-treating eczema: Fear of steroids leads to inadequate control
- Missing allergic triggers: Consider environment, foods, medications in urticaria
- Neglecting adolescent adherence: Assume non-adherence; ask non-judgmentally
- Not providing written plans: Verbal instructions insufficient for chronic disease management
- Overlooking mental health: Anxiety/depression common and affect disease control
🧭 Conclusion
Childhood asthma and allergies represent a spectrum of interconnected conditions that require comprehensive, patient-centered management. Understanding the "atopic march" - the natural progression from eczema to food allergies to allergic rhinitis and asthma - allows for early intervention that may modify disease trajectory.
Effective management combines environmental control (allergen avoidance, smoke-free environments), appropriate pharmacotherapy (stepped approach based on severity), immunotherapy where indicated, and robust patient/family education. The written asthma action plan remains a cornerstone of successful management, empowering families and reducing emergency healthcare utilization.
Special considerations for exercise-induced bronchoconstriction (ensuring full participation in physical activity) and adolescent asthma (addressing unique developmental challenges) require tailored approaches. Emerging therapies including biologics and oral immunotherapy offer new hope for patients with severe, refractory disease.
Prevention strategies, particularly early allergen introduction and aggressive eczema control, may reduce the burden of allergic disease in future generations. Ongoing research continues to refine our understanding of these complex conditions and optimize management approaches.
Holistic allergy care addresses not just physical symptoms but also psychological well-being, social participation, and educational achievement — our goal is children living fully without disease limitations. With comprehensive management, children with asthma and allergies can thrive, participate in all activities, and achieve their full potential.